IM Cannabis Corp
IMCC1.280USD
-0.110-7.91%
Handelsschluss 11/04, 16:00（ET）Kurse um 15 Minuten verzögert
5.18MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über IM Cannabis Corp Unternehmen
IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel. In Germany, the Company operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. It offers four different product lines, leading with the Craft Collection which offers the highest quality Canadian craft cannabis flower. The Company's other product lines include Top-Shelf Collection, Signature Collection and Full Spectrum Extracts. The Company's brands include The WAGNERS, BLKMKT, LOT420, and The PICO collection (minis).
IM Cannabis Corp Informationen
BörsenkürzelIMCC
Name des UnternehmensIM Cannabis Corp
IPO-datumNov 05, 2019
CEOMr. Eyal Fisher
Anzahl der mitarbeiter55
WertpapierartOrdinary Share
GeschäftsjahresendeNov 05
AddresseKibbutz Glil Yam
Stadt
BörseNASDAQ Capital Market Consolidated
LandIsrael
Postleitzahl4690500
Telefon14162564202
Websitehttps://imcannabis.com/
BörsenkürzelIMCC
IPO-datumNov 05, 2019
CEOMr. Eyal Fisher
Führungskräfte von IM Cannabis Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Oren Shuster
Mr. Oren Shuster
Chief Executive Officer, Director
Chief Executive Officer, Director
898.35K
--
Ms. Einat Zakariya
Ms. Einat Zakariya
Independent Director
Independent Director
10.20K
--
Mr. Richard Balla
Mr. Richard Balla
Chief Executive Officer of Adjupharm
Chief Executive Officer of Adjupharm
625.00
-28.57%
Mr. Eliyahu (Eli) Zamir
Mr. Eliyahu (Eli) Zamir
Director
Director
--
--
Mr. Asaf Yitzhaik
Mr. Asaf Yitzhaik
Director
Director
--
--
Mrs. Michal Lebovitz Nissimov
Mrs. Michal Lebovitz Nissimov
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Eyal Fisher
Mr. Eyal Fisher
Chief Executive Officer of IMC Holdings and each of the Israeli Subsidiaries
Chief Executive Officer of IMC Holdings and each of the Israeli Subsidiaries
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Uri Birenberg
Mr. Uri Birenberg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Moti Marcus
Mr. Moti Marcus
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Oren Shuster
Mr. Oren Shuster
Chief Executive Officer, Director
Chief Executive Officer, Director
898.35K
--
Ms. Einat Zakariya
Ms. Einat Zakariya
Independent Director
Independent Director
10.20K
--
Mr. Richard Balla
Mr. Richard Balla
Chief Executive Officer of Adjupharm
Chief Executive Officer of Adjupharm
625.00
-28.57%
Mr. Eliyahu (Eli) Zamir
Mr. Eliyahu (Eli) Zamir
Director
Director
--
--
Mr. Asaf Yitzhaik
Mr. Asaf Yitzhaik
Director
Director
--
--
Mrs. Michal Lebovitz Nissimov
Mrs. Michal Lebovitz Nissimov
General Counsel, Secretary
General Counsel, Secretary
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2022Q1
FY2021
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
Germany
6.80M
53.58%
Israel
5.89M
46.42%
Adjustments
0.00
0.00%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sat, Oct 25
Aktualisiert: Sat, Oct 25
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Shuster (Oren)
17.12%
Molho (Ran)
13.45%
Gabay (Rafael)
9.88%
Lustig (Marc)
2.96%
AdvisorShares Investments, LLC
2.00%
Andere
54.59%
Aktionäre
Aktionäre
Anteil
Shuster (Oren)
17.12%
Molho (Ran)
13.45%
Gabay (Rafael)
9.88%
Lustig (Marc)
2.96%
AdvisorShares Investments, LLC
2.00%
Andere
54.59%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
44.66%
Investment Advisor
4.01%
Research Firm
0.24%
Hedge Fund
0.23%
Investment Advisor/Hedge Fund
0.10%
Andere
50.76%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
33
240.32K
4.58%
-21.61K
2025Q2
38
2.47M
48.05%
+959.10K
2025Q1
38
1.47M
47.74%
-160.92K
2024Q4
42
1.47M
47.79%
+350.95K
2024Q3
48
940.41K
38.51%
-167.62K
2024Q2
52
942.46K
38.60%
-171.69K
2024Q1
56
979.54K
40.26%
-121.50K
2023Q4
56
985.22K
44.75%
-141.95K
2023Q3
65
1.02M
46.98%
-107.12K
2023Q2
70
1.00M
46.23%
+11.21K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Shuster (Oren)
898.35K
17.12%
--
--
Aug 14, 2025
Molho (Ran)
705.67K
13.45%
+705.67K
--
Jun 24, 2025
Gabay (Rafael)
518.52K
9.88%
--
--
Aug 14, 2025
Lustig (Marc)
155.11K
2.96%
--
--
Dec 31, 2024
AdvisorShares Investments, LLC
104.88K
2%
+800.00
+0.77%
Jun 30, 2025
Heron Bay Capital Management, LLC
78.79K
1.5%
+78.79K
--
Jun 30, 2025
Arbel (Shmulik)
54.86K
1.05%
--
--
Mar 31, 2025
Citadel Advisors LLC
12.25K
0.23%
+12.25K
--
Jun 30, 2025
BMO Nesbitt Burns Inc.
12.18K
0.23%
-307.00
-2.46%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sun, Nov 2
Aktualisiert: Sun, Nov 2
Name
Anteil
AdvisorShares Pure Cannabis ETF
0.42%
Amplify Seymour Cannabis ETF
0%
AdvisorShares Pure Cannabis ETF
Anteil0.42%
Amplify Seymour Cannabis ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
Datum
Art
Verhältnis
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
